Johns Stefanie 4
4 · Hoth Therapeutics, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Johns Stefanie
Chief Scientific Officer
Transactions
- Award
Options
2022-03-16+250,000→ 250,000 totalExercise: $0.59From: 2022-03-16Exp: 2032-03-16→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The options were used pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.